Plasma Rich in Growth Factors in Macular Hole Surgery

The aim of this study was to evaluate the use of PRGF (plasma rich in growth factors) as an adjuvant to PPV (pars plana vitrectomy) in recurrent, persistent, or poor prognosis MH (macular hole). Patients with MH were treated with PPV plus adjuvant therapy (PRGF membrane (mPRGF) and injectable liquid...

Full description

Bibliographic Details
Main Authors: Ronald M. Sánchez-Ávila, Carlos A. Robayo-Esper, Eva Villota-Deleu, Álvaro Fernández-Vega Sanz, Álvaro Fernández-Vega González, Borja de la Sen-Corcuera, Eduardo Anitua, Jesús Merayo-Lloves
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/12/1/7